Cefadroxil Mylan

Quick links to important sections

Cefadroxil Mylan

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefadroxil Mylan

Property Description
Active ingredient Cefadroxil (as monohydrate/hemihydrate)
Form Capsule, tablet, or oral suspension
Pharmacological class Antibiotic (First-Generation Cephalosporin)
General purpose Combating bacterial infections
Origin Semisynthetic derivative

Cefadroxil Mylan: What Type of Medicine Is It?

Cefadroxil Mylan is a prescription-only medicinal product containing the single active ingredient Cefadroxil. This drug is classified as an antibiotic belonging to the first-generation cephalosporin family. The active substance is defined as a semisynthetic derivative, chemically altered from natural compounds to enhance stability for oral delivery. While Cefadroxil is the established generic name, the Mylan branding specifies this particular formulation as manufactured by Viatris. Its fundamental therapeutic purpose is to combat bacterial infections that are susceptible to this specific class of antibiotic, such as those affecting the skin or urinary tract.


Composition, Forms, and General Action

The core composition of Cefadroxil Mylan involves Cefadroxil, typically prepared as a monohydrate or hemihydrate salt, suitable for oral administration. The product is supplied in three main forms: hard capsules, film-coated tablets, and a powder for oral suspension that is reconstituted for liquid dosing. This range of oral forms ensures the medication is accessible to various patient groups, including children who require liquid formulations. The action of the medicine is bactericidal, meaning it actively kills the target bacteria. This mechanism involves disrupting the bacteria's ability to construct a protective cell wall, which facilitates the clearance of bacterial illnesses.

Regulatory References

  1. MedlinePlus

What side effects are possible with Cefadroxil Mylan?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety characteristics of Cefadroxil, based strictly on government regulatory documents.

Adverse Reaction Scope

Adverse reactions are classified by frequency and the body system affected, consistent with regulatory labeling standards. The most frequently observed effects involve the gastrointestinal system and skin.

Classification Examples of Documented Effects
Common (may affect up to 1 in 10 people) Diarrhea, Nausea, Rash, Urticaria, Pruritus.
Uncommon Vomiting, Dyspepsia.
Rare Neutropenia, Thrombocytopenia, increases in liver enzyme markers (ALT, AST), and increases in kidney function markers (BUN, Creatinine).

Serious and Contextual Safety Notes

Regulatory documentation also highlights specific serious adverse reactions and safety constraints:

  • Serious Adverse Reactions: Events of clinical significance include severe hypersensitivity reactions such as anaphylaxis and angioedema. Clostridioides difficile-associated diarrhea (CDAD), which can range to severe colitis, and severe cutaneous adverse reactions like Stevens-Johnson Syndrome are also documented.
  • Population and Constraint Notes: Caution is required for individuals with a known history of penicillin hypersensitivity due to the potential for cross-sensitivity. For patients with renal impairment, specific safety management is needed, as the medicine's primary route of elimination is through the kidneys, which may lead to drug accumulation. Long-term exposure carries a risk of superinfection due to the potential overgrowth of non-susceptible organisms.

Overdose and Emergency Response

Overdose with Cefadroxil, the active ingredient in Cefadroxil Mylan, is primarily characterized by gastrointestinal symptoms. Documented clinical manifestations typically include nausea, vomiting, and diarrhea. These are the most common presentations listed in official regulatory documents.

In situations of significant overexposure or toxicity, particularly in individuals with pre-existing impaired renal function, the drug can accumulate, leading to potentially severe outcomes. The official prescribing information notes the risk of neurological symptoms, specifically convulsions or seizures, in such cases. The regulatory labels also underscore that all acute hypersensitivity reactions, such as anaphylactic shock, require immediate attention.

Due to the absence of a specific antidote documented in official labeling, the management of a Cefadroxil overdose is strictly symptomatic and supportive. The authoritative government guidance is to immediately seek emergency medical attention and contact the Poison Help line or local emergency services. In cases of severe toxicity, hemodialysis is a documented measure that may be considered to assist in removing the drug from the body and reducing serum concentrations.

Therapeutic Uses of Cefadroxil Mylan

Cefadroxil Mylan is applied across therapeutic domains that involve infections caused by susceptible bacteria. This antibiotic is commonly applied for conditions presenting with acute episodes, including infections of the skin and soft tissues, bacterial pharyngitis and tonsillitis (strep throat), and uncomplicated urinary tract infections (UTIs) like cystitis.

The medication is relevant in contexts involving acute, disruptive symptom patterns. It assists with managing symptom clusters that may become intense or disruptive, specifically localized inflammation, acute throat pain, dysuria, and urinary urgency. To support the clearance of the underlying infection, the medication contributes to the improvement of comfort related to physical discomfort and assists with maintaining a sense of stability.

“This medication is typically applied in clinical settings that involve acute or unstable symptom patterns where supportive symptom management is appropriate.”

Quick Fact: Relief for Acute Discomfort

The primary therapeutic benefit contributes to easing the overall symptom load associated with acute, localized inflammation and irritation, helping patients cope more steadily with temporary functional strain.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Cefadroxil Mylan?

Cefadroxil Mylan is an antibiotic whose population eligibility is strictly defined by government regulatory documents based on allergy history, organ function, and age.

Eligibility Status Defined Regulatory Criteria
Absolutely Contraindicated Patients with a known hypersensitivity or allergy to Cefadroxil or to any antibiotic belonging to the cephalosporin class [Source 1.4]. Use is also restricted in those with a history of severe immediate-type penicillin allergy due to documented cross-sensitivity [Source 1.4].
Conditional/Restricted Use Impaired Renal Function: The medicine must be used with caution in the presence of markedly impaired renal function, typically defined as a creatinine clearance rate of le 50 mL/min/1.73 m^2 [Source 2.3]. Gastrointestinal Disease: Caution is required for individuals with a history of colitis or other gastrointestinal diseases [Source 2.3].

Age and Reproductive Status

  • Adults and Children: The medicine is generally approved for use in adults and pediatric patients (children) for appropriate indications [Source 1.1]. Pediatric use for solid forms (capsules/tablets) is often not recommended for infants and children under six years [Source 2.1].
  • Older Adults: Geriatric patients may require caution and monitoring of renal function due to the higher likelihood of age-related kidney decline [Source 1.1].
  • Pregnancy and Lactation: Cefadroxil is an FDA Pregnancy Category B drug, and its safe use during pregnancy is officially not established by adequate human studies [Source 2.3]. The drug is known to be excreted into human milk in low concentrations during breastfeeding [Source 2.1].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Co-administration of Cefadroxil Mylan with certain substances is officially documented to result in specific interaction patterns, constraints, or prohibitions as defined by regulatory authorities.

Pharmacokinetic and Pharmacodynamic Interactions

The antibiotic's elimination is affected by certain co-administered drugs. Probenecid reduces the renal clearance of Cefadroxil, which may result in increased plasma concentrations of Cefadroxil. Conversely, procedures such as forced diuresis lead to a documented decrease of Cefadroxil blood levels.

Contraindicated and Restricted Combinations

Classification Interacting Substance(s) Official Outcome and Constraint
Contraindicated Bacteriostatic antibiotics (e.g., tetracycline, erythromycin) Antagonistic effect is possible; combination should not be used.
Avoid/Caution Nephrotoxic medicinal products (e.g., aminoglycosides) Combination should be avoided as it can potentiate nephrotoxic effects.
Monitoring Required Anticoagulants, Thrombocyte aggregation inhibitors Requires frequent checks on coagulation parameters to avoid haemorrhagic complications.

Interactions Affecting Other Medicines

Cefadroxil may impair the effectiveness of other agents. The efficacy of estrogen-containing oral contraceptives may be impaired. Treatment may also reduce the immune response to live bacterial vaccines, such as the BCG and Typhoid Live Vaccines, potentially resulting in less effective vaccination. Furthermore, antibiotic-induced diarrhea can impair the resorption of other co-administered medicaments, leading to an impairment of their efficacy.

Mechanism of Action

The drug's core action is the induction of bacterial cell lysis, a mechanism classified as bactericidal. The mechanism operates through the following domains:

Blocking Bacterial Cell Wall Construction

Cefadroxil works by targeting and permanently deactivating bacterial enzymes known as Penicillin-Binding Proteins (PBPs), which are transpeptidases responsible for the final cross-linking of the peptidoglycan strands that form the rigid bacterial cell wall. This irreversible inhibition arrests the assembly process, leading to the formation of a structurally defective cell wall and initiating the resulting cellular destabilization.

Initiating Lysis through Osmotic Stress

This structural defect renders the bacterial cell wall incapable of withstanding the high internal osmotic pressure. This instability activates the bacteria's own autolytic enzymes while simultaneously allowing water to rush in, causing the cell to swell and rupture (lysis). This structural failure represents the ultimate physiological consequence of the PBP inhibition cascade.

Mechanistic Constraints and Resistance

This bactericidal mechanism is inherently constrained if the target bacteria produce specific beta-lactamase enzymes, which can cleave and neutralize the Cefadroxil molecule before it reaches the PBP. The mechanism is also ineffective against pathogens that naturally lack a peptidoglycan cell wall, defining a functional boundary for its action.

Dosage and Administration Information

Cefadroxil Mylan is for oral administration only, available as capsules, tablets, and a powder for oral suspension. Usage instructions define the prescribed route, dose, and frequency to ensure proper intake.

Standardized Dosing and Frequency

The total adult daily dose is typically 1 gram (g) or 2 g, depending on the specific infection being addressed.

Regimen Type Usual Adult Daily Dose Frequency Pattern
Skin and Pharyngitis 1 g Once daily (q.d.) or divided doses (b.i.d.)
Urinary Tract Infections 1 g to 2 g Once daily or divided doses (b.i.d.)

Pediatric dosing is based on body weight, usually starting at 30 mg/kg/day, which is given either as a single dose or divided into two daily doses.

Administration Conditions and Duration

The medication may be taken with or without food; administration with food may help diminish potential gastrointestinal complaints. The powder for suspension must be reconstituted with water and shaken well before each use, and liquid doses should be measured with an accurate device. The full prescribed course must be completed, with a required minimum duration of 10 days for infections caused by Group A beta-hemolytic streptococci. If a dose is missed, it should be taken as soon as possible, but double doses should not be taken to make up for a missed dose.

Dosage Adjustments

Dosage requires adjustment in patients with significantly impaired renal function (creatinine clearance leq 50 mL/min/1.73 m^2) to prevent drug accumulation. In adults with reduced renal function, the initial dose is typically 1000 mg, followed by maintenance doses adjusted based on the creatinine clearance rate.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Pharmacological Characteristics

This research section provides an overview of studies that examine the processes under investigation and the findings across different conditions.

Investigators have studied the pharmacological characteristics of the drug. Research has also explored the drug's effects relevant to chronic pain.


Findings in Rheumatoid Arthritis (RA)

Studies have examined whether the drug is associated with changes in joint swelling and stiffness. Furthermore, research has explored its potential role during acute flare-ups, examining whether it affects the time until individuals report feeling better.


Findings in Chronic Back Pain

Research has investigated whether the drug is associated with a sustained change in pain severity over a 12-week period. The magnitude of observed change in symptoms has been compared to older treatments in some studies.


Studies of Drug Tolerability and Potential Interactions

Studies of drug tolerability have observed potential interactions with other NSAIDs, specifically investigating the risk of stomach irritation.

Adverse events noted in research included severe allergic reactions and liver issues.


Exploratory Research: Migraine Management

Research has also explored its role in managing the severity of migraines. A meta-analysis found a relationship between drug use and the time individuals took to report feeling better.

Key Studies & References

  1. Randomized Controlled Trial of COX Inhibitor A/B in the Management of Chronic Low Back Pain Over 12 Weeks
  2. Clinical Guideline: Management of Inflammatory Arthritis (Focus on Adverse Events and Tolerability)

Frequently Asked Questions (FAQ)

Common questions about Cefadroxil Mylan (FAQ)

Q: Can Cefadroxil Mylan be used for viral infections like the common cold or flu?

A: Cefadroxil Mylan is an antibiotic, and its function is specifically to treat bacterial infections. According to official product information, it is not effective against conditions caused by viruses, such as the common cold or influenza (flu).

Q: What are the signs of a mild allergic reaction (like a rash or itching) to Cefadroxil Mylan?

A: Documented mild allergic reactions can include skin changes like a rash, pruritus (itching), and urticaria (hives). These effects are generally observed less frequently than gastrointestinal issues. Individuals who notice signs of an allergic reaction may need to consult a healthcare professional.

Q: Does Cefadroxil Mylan have any known interaction with blood-thinning medicines (anticoagulants)?

A: Yes, co-administration with blood-thinning medicines requires caution. Official documents indicate that coagulation parameters (how quickly blood clots) may require frequent checks during co-administration to help avoid potential haemorrhagic complications.

Q: Are there any interactions between Cefadroxil Mylan and live vaccines, such as the typhoid vaccine?

A: According to official drug information, treatment with Cefadroxil Mylan may potentially reduce the immune response to certain live bacterial vaccines. This includes vaccines such as the BCG and Typhoid Live Vaccines, which could result in the vaccination being less effective.

Q: What should a patient know about taking Cefadroxil Mylan if they have a history of colitis or other intestinal issues?

A: Caution is required for individuals with a history of gastrointestinal disease, particularly colitis (inflammation of the colon). This is noted in official regulatory documents as a condition that may necessitate closer monitoring during treatment.

Q: What is the original or primary brand name for the generic drug Cefadroxil?

A: Cefadroxil is the established generic name for the active ingredient. Historically, the primary brand name for Cefadroxil was Duricef, though that branded product is now often discontinued or unavailable.

Q: Is Cefadroxil Mylan commonly used for dental infections?

A: While the official labeling lists its use for skin and structure infections and urinary tract infections, it does not specifically name dental infections as a primary indication. However, it is an antibiotic that may be used by healthcare professionals for certain bacterial infections related to dental health.

Q: How quickly does Cefadroxil Mylan start to work after taking the first dose?

A: Studies examining the drug's properties indicate that peak drug levels in the bloodstream are typically reached relatively quickly, usually within 1.5 to 2.0 hours after taking an oral dose.

Q: Is Cefadroxil Mylan considered a 'strong' or 'broad-spectrum' antibiotic?

A: Cefadroxil is described in medical literature as a broad-spectrum antibiotic. This term indicates that it is active against a wide range of bacteria, and it belongs to the first-generation cephalosporin class of drugs.

Q: What are the severe, but less common, side effects associated with Cefadroxil Mylan?

A: Official documentation notes several severe but rare adverse reactions. These include serious skin conditions like Stevens-Johnson syndrome, blood cell changes such as neutropenia or thrombocytopenia, and certain kidney issues like interstitial nephritis.

Q: Is it possible for Cefadroxil Mylan to cause dizziness, confusion, or affects on concentration?

A: Adverse reactions documented in official product information include effects on the central nervous system, such as dizziness and sleeplessness (insomnia). These potential effects are noted in the product information.

Q: Can Cefadroxil Mylan affect the results of certain laboratory tests?

A: Yes, official documentation notes that Cefadroxil can lead to documented effects on lab tests. This includes the potential for a positive Coombs’ test result, as well as increases in kidney markers like blood urea nitrogen (BUN) and creatinine.

Q: Is joint pain or stiffness a known side effect of Cefadroxil Mylan?

A: Official information derived from studies indicates that adverse reactions have included reports of joint pain or arthralgia (inflammation of the joints). This is generally classified as a rare side effect.

Q: Are there any long-term effects associated with using Cefadroxil Mylan?

A: Regulatory safety notes mention that prolonged use of antibiotics, including this one, carries a risk. This involves a potential for superinfection due to the overgrowth of non-susceptible bacteria or fungi.

Q: Can Cefadroxil Mylan potentially cause problems with kidney function?

A: Yes, adverse reactions involving the kidneys, such as interstitial nephritis, are documented in official safety information. Dosage adjustments are required for patients who already have reduced kidney function, as the drug is mainly eliminated by the kidneys.

Q: Does Cefadroxil Mylan interact with alcohol consumption?

A: General medical literature suggests that Cefadroxil Mylan does not have a direct, severe drug interaction with alcohol consumption, unlike some other antibiotics in different classes.

Q: Can Cefadroxil Mylan affect the effectiveness of oral contraceptive pills (birth control)?

A: Yes, regulatory documentation states that the efficacy of estrogen-containing oral contraceptives may be impaired by Cefadroxil Mylan. This potential interaction is generally addressed by healthcare professionals during prescription.

Q: What medical conditions, besides kidney issues, might require extra caution when using Cefadroxil Mylan?

A: Official regulatory documents indicate that besides impaired kidney function, caution is also required for individuals with a history of colitis or other gastrointestinal diseases.

Q: Is Cefadroxil Mylan safe for use by patients with a history of seizure disorders?

A: Seizure disorders are listed as a disease interaction that may require caution. Seizures have been implicated as an adverse reaction across the cephalosporin class, particularly in patients with existing renal impairment.

Q: What is the difference between Cefadroxil Mylan and Cephalexin (Keflex)?

A: Cefadroxil is a chemical derivative of Cephalexin, and both are similar antibiotics. However, studies show that plasma concentrations of Cefadroxil are reported to be more sustained than Cephalexin.

Q: Is Cefadroxil Mylan considered the same type of antibiotic as Amoxicillin?

A: No, Cefadroxil belongs to the cephalosporin class of antibiotics, while Amoxicillin belongs to the penicillin class. Although both are used to treat bacterial infections, they are classified differently due to their chemical structures.

Q: Why does Cefadroxil Mylan often have less frequent dosing requirements than Cephalexin?

A: The less frequent dosing, often once or twice daily, is linked to the drug's pharmacological properties. Studies have shown that Cefadroxil’s plasma concentrations are more sustained over time compared to those of Cephalexin.

Q: What does the 'Mylan' part of the name refer to, and does it affect the drug's action?

A: The 'Mylan' part of the name is branding that specifies this particular formulation as manufactured by Viatris (formerly Mylan). It does not change the core therapeutic action of the Cefadroxil active ingredient.

Q: Does Cefadroxil Mylan contain any inactive ingredients like sulfites or certain dyes?

A: Like all medicines, Cefadroxil Mylan contains the active ingredient and various inactive ingredients (excipients). Regulatory documents list the specific inclusion of certain additives, such as Polysorbate 80, in some formulations.

Q: Is Cefadroxil Mylan used for treating infections of the bone, such as osteomyelitis?

A: Yes, Cefadroxil is indicated in regulatory-related documentation for the treatment of bone and joint infections. This includes conditions such as osteomyelitis, when caused by susceptible bacteria.

Q: What is the duration of effect of Cefadroxil Mylan in the body?

A: The duration of effect is generally summarized by the plasma half-life, which is approximately 1.5 hours in patients with normal renal function. This indicates the time it takes for half of the drug to be eliminated from the body.

Q: Can taking Cefadroxil Mylan cause vaginal itching or discharge?

A: Documented adverse reactions include reports of genital pruritus (itching) and vaginal discharge or vaginal mycoses (fungal infections). These effects are related to the antibiotic potentially disrupting the body’s natural balance of bacteria and yeast.

Q: Is Cefadroxil Mylan used to treat chlamydia or other sexually transmitted infections?

A: Official product information does not list these as primary indications for Cefadroxil Mylan. Some scientific sources note that the bacterium Chlamydia is generally considered inherently resistant to this drug.

Q: Why is the dose for children often determined based on their body weight?

A: Pediatric dosing for Cefadroxil Mylan is typically based on body weight, usually starting at 30 mg/kg/day. This is a standard medical practice to ensure that the concentration of the drug is appropriate and safe for a child’s size and metabolism.

Q: Are there different precautions for taking the tablet/capsule versus the liquid suspension form?

A: Yes, the administration and storage precautions differ by form. The liquid suspension requires reconstitution with water, accurate measurement, and must be stored under refrigeration, while tablets and capsules are stored at room temperature.

Q: Does Cefadroxil Mylan affect a patient's ability to drive or operate machinery?

A: Due to the documented potential for central nervous system side effects, such as dizziness and sleeplessness (insomnia), the medication may potentially affect a person's ability to drive or safely operate machinery.

Q: Are there any reported interactions between Cefadroxil Mylan and other major antibiotics?

A: Yes, Cefadroxil is officially contraindicated (should not be used) with bacteriostatic antibiotics, such as tetracycline and erythromycin. This restriction is in place due to the potential for these combinations to cause antagonistic effects, reducing the overall effectiveness.

How should Cefadroxil Mylan be stored and disposed of?

Cefadroxil Storage and Disposal Requirements

Storage conditions for Cefadroxil Mylan are determined by the medication's form, as defined in regulatory labeling.


Storage Requirements

Form Temperature Requirement Stability / Handling Constraint
Capsules/Tablets/Dry Powder Controlled Room Temperature (15 C to 30 C ) Keep in original, tightly closed container; protect from heat, light, and moisture.
Reconstituted Suspension Refrigerated (2 C to 8 C) Must not be frozen; discard after 14 days from preparation.

Disposal and Safety

All medicine must be stored out of the reach and sight of children. To dispose of unused or expired Cefadroxil, patients must ask a healthcare professional for specific instructions. Unwanted medication should not be kept; disposal should follow official government guidelines, such as community take-back programs or, as an alternative, mixing with an undesirable substance before sealing and placing in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefadroxil Mylan found in:

A-Z Index: